Blueprint Medicines Corporation (NASDAQ:BPMC) Q3 2023 Earnings Call Transcript

Blueprint Medicines Corporation (NASDAQ:BPMC) Q3 2023 Earnings Call Transcript October 26, 2023

Blueprint Medicines Corporation beats earnings expectations. Reported EPS is $-2.2, expectations were $-2.39.

Operator: Good morning. My name is Elliot and I will be your conference operator today. At this time, I would like to welcome everyone to the Blueprint Medicines’ Third Quarter 2023 Financial Results Conference Call. All lines have been on placed on mute to prevent any background noise....